Companion Society Meetings
The Society for Cardiovascular Pathology
Myocardial Maladies: An Update on Congenital And Acquired Diseases Of The Myocardium
Sunday, March 18, 2018, 8:30 AM - 12:00 PM
3 CME and 3 SAMs
Joseph J. Maleszewski, MD, Mayo Clinic, Rochester, MN
Cristina Basso, MD, University of Padua, Padua, Italy
Although myocardial disease has long been recognized as a significant cause of morbidity and mortality, our understanding of such has increased exponentially over the last decade. This is, in part, due to the wealth of information that has flooded the landscape since the sequencing of the human genome. Additionally, new diseases are being recognized, both because of this more complete understanding of genomics and proteomics as well as a consequence of new unintended injury resulting from contemporary therapies. This session will update the audience on the latest developments in myocardial disease, focusing on diagnostic strategies, emerging ancillary studies and how they impact therapy. The session will be capped by Drs. Christine and Jonathan Seidman, the 2018 recipients of the Society for Cardiovascular Pathology's Distinguished Achievement Award, speaking on the molecular landscape of myocardial disease.
Upon completion of this educational activity, the learner will be able to:
- Describe common genetic and non-genetic causes of myocardial disease
- Identify key morphologic features of myocardial disease
- Discuss standard and ancillary diagnostic techniques that are used in the evaluation of myocardial disease
|8:30 AM||Myocardial Toxins: The Forensic Pathology Perspective
Stephen Cohle, MD, Spectrum Health, Grand Rapids, MI
|9:00 AM||Winning the Battle, but Losing the War: Mechanisms and Morphology of Cancer Therapy-Associated Cardiovascular Toxicity
Richard N. Mitchell, MD, PhD, Brigham and Womens Hospital, Boston, MA
|9:30 AM||Cellular indigestion and heart disease: Lysosomal Storage Disorders Affecting the Heart
Vidhya Nair, MBBS, MD, McMaster University and Hamilton General Hospital, Hamilton, ON, Canada
|10:30 AM||Myocarditis: A Clinicianas' perspective on diagnosis and management in 2018
Les Cooper, MD, Mayo Clinic, Jacksonville, FL
|11:00 AM||Hypertrophic Cardiomyopathy: Getting to the Heart of the Matter
Christine Seidman, MD and Jonathan Seidman, PhD
Continuing Medical Education and Maintenance of Certification
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and The Society for Cardiovascular Pathology. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this live activity for a maximum of
3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Physicians must take and pass the post-test in order to claim SAMs credit.
Physicians can earn a maximum of 3 SAM credit hours.